Sulfated glycosaminoglycans inhibit transglutaminase 2 by stabilizing its closed conformation

Transglutaminases (TGs) catalyze the covalent crosslinking of proteins via isopeptide bonds. The most prominent isoform, TG2, is associated with physiological processes such as extracellular matrix (ECM) stabilization and plays a crucial role in the pathogenesis of e.g. fibrotic diseases, cancer and...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2022-08, Vol.12 (1), p.13326-13326, Article 13326
Main Authors: Müller, Claudia Damaris, Ruiz-Gómez, Gloria, Cazzonelli, Sophie, Möller, Stephanie, Wodtke, Robert, Löser, Reik, Freyse, Joanna, Dürig, Jan-Niklas, Rademann, Jörg, Hempel, Ute, Pisabarro, M. Teresa, Vogel, Sarah
Format: Article
Language:English
Subjects:
631/114
631/45
631/535
631/92
Binding sites
Cancer
Celiac disease
Cell adhesion & migration
Chemical bonds
Chondroitin sulfate
Conformation
Enzymes
Extracellular matrix
Glycosaminoglycans
Heparan sulfate
Heparin
Humanities and Social Sciences
Hyaluronic acid
Molecular modelling
multidisciplinary
Peptides
Physiology
Proteins
Science
Science (multidisciplinary)
Sulfates
Transglutaminase 2
Wound healing
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c447t-57c9e2fb39c1b41c6057209c4cedf9bcd6bef04f52c6b2f6262dd940d51af3d13
cites cdi_FETCH-LOGICAL-c447t-57c9e2fb39c1b41c6057209c4cedf9bcd6bef04f52c6b2f6262dd940d51af3d13
container_end_page 13326
container_issue 1
container_start_page 13326
container_title Scientific reports
container_volume 12
creator Müller, Claudia Damaris
Ruiz-Gómez, Gloria
Cazzonelli, Sophie
Möller, Stephanie
Wodtke, Robert
Löser, Reik
Freyse, Joanna
Dürig, Jan-Niklas
Rademann, Jörg
Hempel, Ute
Pisabarro, M. Teresa
Vogel, Sarah
description Transglutaminases (TGs) catalyze the covalent crosslinking of proteins via isopeptide bonds. The most prominent isoform, TG2, is associated with physiological processes such as extracellular matrix (ECM) stabilization and plays a crucial role in the pathogenesis of e.g. fibrotic diseases, cancer and celiac disease. Therefore, TG2 represents a pharmacological target of increasing relevance. The glycosaminoglycans (GAG) heparin (HE) and heparan sulfate (HS) constitute high-affinity interaction partners of TG2 in the ECM. Chemically modified GAG are promising molecules for pharmacological applications as their composition and chemical functionalization may be used to tackle the function of ECM molecular systems, which has been recently described for hyaluronan (HA) and chondroitin sulfate (CS). Herein, we investigate the recognition of GAG derivatives by TG2 using an enzyme-crosslinking activity assay in combination with in silico molecular modeling and docking techniques. The study reveals that GAG represent potent inhibitors of TG2 crosslinking activity and offers atom-detailed mechanistic insights.
doi_str_mv 10.1038/s41598-022-17113-2
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ec1ce90abb794cc0b3ccdc64ff3a478e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_ec1ce90abb794cc0b3ccdc64ff3a478e</doaj_id><sourcerecordid>2698631931</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-57c9e2fb39c1b41c6057209c4cedf9bcd6bef04f52c6b2f6262dd940d51af3d13</originalsourceid><addsrcrecordid>eNp9kk1rFTEUhgdRbKn9A64G3LgZm8-Zm40gxY9CwYW6lJCcJNNccpOaZITrrzfTKda6MJuc5Lzvw0l4u-4lRm8woruLwjAXuwERMuAJYzqQJ90pQYwPhBLy9K_6pDsvZY_a4kQwLJ53J5QLQjilp933L0twqlrTz-EIqaiDj2ktVSy9jzde-9rX3E5zWOraVcX2pNfHvlSlffC_fJx7X0sPIZXGgRRdygdVfYovumdOhWLP7_ez7tuH918vPw3Xnz9eXb67HoCxqQ58AmGJ01QA1gzDiPhEkAAG1jihwYzaOsQcJzBq4kYyEmMEQ4Zj5ajB9Ky72rgmqb28zf6g8lEm5eXdRcqzVLl6CFZawGAFUlpPggEgTQEMjMw5qti0s431dmPdLvpgDdjYnh8eQR93or-Rc_opBWUCC9EAr-8BOf1YbKny4AvYEFS0aSmSjGI3UizoOverf6T7tOTYvmpVTZxOmE5NRTYV5FRKtu7PMBjJNQxyC4NsYZB3YZCkmehmKk0cZ5sf0P9x_QZaC7ka</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2697537137</pqid></control><display><type>article</type><title>Sulfated glycosaminoglycans inhibit transglutaminase 2 by stabilizing its closed conformation</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central(OpenAccess)</source><source>Full-Text Journals in Chemistry (Open access)</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Müller, Claudia Damaris ; Ruiz-Gómez, Gloria ; Cazzonelli, Sophie ; Möller, Stephanie ; Wodtke, Robert ; Löser, Reik ; Freyse, Joanna ; Dürig, Jan-Niklas ; Rademann, Jörg ; Hempel, Ute ; Pisabarro, M. Teresa ; Vogel, Sarah</creator><creatorcontrib>Müller, Claudia Damaris ; Ruiz-Gómez, Gloria ; Cazzonelli, Sophie ; Möller, Stephanie ; Wodtke, Robert ; Löser, Reik ; Freyse, Joanna ; Dürig, Jan-Niklas ; Rademann, Jörg ; Hempel, Ute ; Pisabarro, M. Teresa ; Vogel, Sarah</creatorcontrib><description>Transglutaminases (TGs) catalyze the covalent crosslinking of proteins via isopeptide bonds. The most prominent isoform, TG2, is associated with physiological processes such as extracellular matrix (ECM) stabilization and plays a crucial role in the pathogenesis of e.g. fibrotic diseases, cancer and celiac disease. Therefore, TG2 represents a pharmacological target of increasing relevance. The glycosaminoglycans (GAG) heparin (HE) and heparan sulfate (HS) constitute high-affinity interaction partners of TG2 in the ECM. Chemically modified GAG are promising molecules for pharmacological applications as their composition and chemical functionalization may be used to tackle the function of ECM molecular systems, which has been recently described for hyaluronan (HA) and chondroitin sulfate (CS). Herein, we investigate the recognition of GAG derivatives by TG2 using an enzyme-crosslinking activity assay in combination with in silico molecular modeling and docking techniques. The study reveals that GAG represent potent inhibitors of TG2 crosslinking activity and offers atom-detailed mechanistic insights.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-022-17113-2</identifier><identifier>PMID: 35922533</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/114 ; 631/45 ; 631/535 ; 631/92 ; Binding sites ; Cancer ; Celiac disease ; Cell adhesion &amp; migration ; Chemical bonds ; Chondroitin sulfate ; Conformation ; Enzymes ; Extracellular matrix ; Glycosaminoglycans ; Heparan sulfate ; Heparin ; Humanities and Social Sciences ; Hyaluronic acid ; Molecular modelling ; multidisciplinary ; Peptides ; Physiology ; Proteins ; Science ; Science (multidisciplinary) ; Sulfates ; Transglutaminase 2 ; Wound healing</subject><ispartof>Scientific reports, 2022-08, Vol.12 (1), p.13326-13326, Article 13326</ispartof><rights>The Author(s) 2022. corrected publication 2022</rights><rights>The Author(s) 2022. corrected publication 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2022, corrected publication 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-57c9e2fb39c1b41c6057209c4cedf9bcd6bef04f52c6b2f6262dd940d51af3d13</citedby><cites>FETCH-LOGICAL-c447t-57c9e2fb39c1b41c6057209c4cedf9bcd6bef04f52c6b2f6262dd940d51af3d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2697537137/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2697537137?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids></links><search><creatorcontrib>Müller, Claudia Damaris</creatorcontrib><creatorcontrib>Ruiz-Gómez, Gloria</creatorcontrib><creatorcontrib>Cazzonelli, Sophie</creatorcontrib><creatorcontrib>Möller, Stephanie</creatorcontrib><creatorcontrib>Wodtke, Robert</creatorcontrib><creatorcontrib>Löser, Reik</creatorcontrib><creatorcontrib>Freyse, Joanna</creatorcontrib><creatorcontrib>Dürig, Jan-Niklas</creatorcontrib><creatorcontrib>Rademann, Jörg</creatorcontrib><creatorcontrib>Hempel, Ute</creatorcontrib><creatorcontrib>Pisabarro, M. Teresa</creatorcontrib><creatorcontrib>Vogel, Sarah</creatorcontrib><title>Sulfated glycosaminoglycans inhibit transglutaminase 2 by stabilizing its closed conformation</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><description>Transglutaminases (TGs) catalyze the covalent crosslinking of proteins via isopeptide bonds. The most prominent isoform, TG2, is associated with physiological processes such as extracellular matrix (ECM) stabilization and plays a crucial role in the pathogenesis of e.g. fibrotic diseases, cancer and celiac disease. Therefore, TG2 represents a pharmacological target of increasing relevance. The glycosaminoglycans (GAG) heparin (HE) and heparan sulfate (HS) constitute high-affinity interaction partners of TG2 in the ECM. Chemically modified GAG are promising molecules for pharmacological applications as their composition and chemical functionalization may be used to tackle the function of ECM molecular systems, which has been recently described for hyaluronan (HA) and chondroitin sulfate (CS). Herein, we investigate the recognition of GAG derivatives by TG2 using an enzyme-crosslinking activity assay in combination with in silico molecular modeling and docking techniques. The study reveals that GAG represent potent inhibitors of TG2 crosslinking activity and offers atom-detailed mechanistic insights.</description><subject>631/114</subject><subject>631/45</subject><subject>631/535</subject><subject>631/92</subject><subject>Binding sites</subject><subject>Cancer</subject><subject>Celiac disease</subject><subject>Cell adhesion &amp; migration</subject><subject>Chemical bonds</subject><subject>Chondroitin sulfate</subject><subject>Conformation</subject><subject>Enzymes</subject><subject>Extracellular matrix</subject><subject>Glycosaminoglycans</subject><subject>Heparan sulfate</subject><subject>Heparin</subject><subject>Humanities and Social Sciences</subject><subject>Hyaluronic acid</subject><subject>Molecular modelling</subject><subject>multidisciplinary</subject><subject>Peptides</subject><subject>Physiology</subject><subject>Proteins</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Sulfates</subject><subject>Transglutaminase 2</subject><subject>Wound healing</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kk1rFTEUhgdRbKn9A64G3LgZm8-Zm40gxY9CwYW6lJCcJNNccpOaZITrrzfTKda6MJuc5Lzvw0l4u-4lRm8woruLwjAXuwERMuAJYzqQJ90pQYwPhBLy9K_6pDsvZY_a4kQwLJ53J5QLQjilp933L0twqlrTz-EIqaiDj2ktVSy9jzde-9rX3E5zWOraVcX2pNfHvlSlffC_fJx7X0sPIZXGgRRdygdVfYovumdOhWLP7_ez7tuH918vPw3Xnz9eXb67HoCxqQ58AmGJ01QA1gzDiPhEkAAG1jihwYzaOsQcJzBq4kYyEmMEQ4Zj5ajB9Ky72rgmqb28zf6g8lEm5eXdRcqzVLl6CFZawGAFUlpPggEgTQEMjMw5qti0s431dmPdLvpgDdjYnh8eQR93or-Rc_opBWUCC9EAr-8BOf1YbKny4AvYEFS0aSmSjGI3UizoOverf6T7tOTYvmpVTZxOmE5NRTYV5FRKtu7PMBjJNQxyC4NsYZB3YZCkmehmKk0cZ5sf0P9x_QZaC7ka</recordid><startdate>20220803</startdate><enddate>20220803</enddate><creator>Müller, Claudia Damaris</creator><creator>Ruiz-Gómez, Gloria</creator><creator>Cazzonelli, Sophie</creator><creator>Möller, Stephanie</creator><creator>Wodtke, Robert</creator><creator>Löser, Reik</creator><creator>Freyse, Joanna</creator><creator>Dürig, Jan-Niklas</creator><creator>Rademann, Jörg</creator><creator>Hempel, Ute</creator><creator>Pisabarro, M. Teresa</creator><creator>Vogel, Sarah</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220803</creationdate><title>Sulfated glycosaminoglycans inhibit transglutaminase 2 by stabilizing its closed conformation</title><author>Müller, Claudia Damaris ; Ruiz-Gómez, Gloria ; Cazzonelli, Sophie ; Möller, Stephanie ; Wodtke, Robert ; Löser, Reik ; Freyse, Joanna ; Dürig, Jan-Niklas ; Rademann, Jörg ; Hempel, Ute ; Pisabarro, M. Teresa ; Vogel, Sarah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-57c9e2fb39c1b41c6057209c4cedf9bcd6bef04f52c6b2f6262dd940d51af3d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>631/114</topic><topic>631/45</topic><topic>631/535</topic><topic>631/92</topic><topic>Binding sites</topic><topic>Cancer</topic><topic>Celiac disease</topic><topic>Cell adhesion &amp; migration</topic><topic>Chemical bonds</topic><topic>Chondroitin sulfate</topic><topic>Conformation</topic><topic>Enzymes</topic><topic>Extracellular matrix</topic><topic>Glycosaminoglycans</topic><topic>Heparan sulfate</topic><topic>Heparin</topic><topic>Humanities and Social Sciences</topic><topic>Hyaluronic acid</topic><topic>Molecular modelling</topic><topic>multidisciplinary</topic><topic>Peptides</topic><topic>Physiology</topic><topic>Proteins</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Sulfates</topic><topic>Transglutaminase 2</topic><topic>Wound healing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Müller, Claudia Damaris</creatorcontrib><creatorcontrib>Ruiz-Gómez, Gloria</creatorcontrib><creatorcontrib>Cazzonelli, Sophie</creatorcontrib><creatorcontrib>Möller, Stephanie</creatorcontrib><creatorcontrib>Wodtke, Robert</creatorcontrib><creatorcontrib>Löser, Reik</creatorcontrib><creatorcontrib>Freyse, Joanna</creatorcontrib><creatorcontrib>Dürig, Jan-Niklas</creatorcontrib><creatorcontrib>Rademann, Jörg</creatorcontrib><creatorcontrib>Hempel, Ute</creatorcontrib><creatorcontrib>Pisabarro, M. Teresa</creatorcontrib><creatorcontrib>Vogel, Sarah</creatorcontrib><collection>SpringerOpen</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Müller, Claudia Damaris</au><au>Ruiz-Gómez, Gloria</au><au>Cazzonelli, Sophie</au><au>Möller, Stephanie</au><au>Wodtke, Robert</au><au>Löser, Reik</au><au>Freyse, Joanna</au><au>Dürig, Jan-Niklas</au><au>Rademann, Jörg</au><au>Hempel, Ute</au><au>Pisabarro, M. Teresa</au><au>Vogel, Sarah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sulfated glycosaminoglycans inhibit transglutaminase 2 by stabilizing its closed conformation</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><date>2022-08-03</date><risdate>2022</risdate><volume>12</volume><issue>1</issue><spage>13326</spage><epage>13326</epage><pages>13326-13326</pages><artnum>13326</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Transglutaminases (TGs) catalyze the covalent crosslinking of proteins via isopeptide bonds. The most prominent isoform, TG2, is associated with physiological processes such as extracellular matrix (ECM) stabilization and plays a crucial role in the pathogenesis of e.g. fibrotic diseases, cancer and celiac disease. Therefore, TG2 represents a pharmacological target of increasing relevance. The glycosaminoglycans (GAG) heparin (HE) and heparan sulfate (HS) constitute high-affinity interaction partners of TG2 in the ECM. Chemically modified GAG are promising molecules for pharmacological applications as their composition and chemical functionalization may be used to tackle the function of ECM molecular systems, which has been recently described for hyaluronan (HA) and chondroitin sulfate (CS). Herein, we investigate the recognition of GAG derivatives by TG2 using an enzyme-crosslinking activity assay in combination with in silico molecular modeling and docking techniques. The study reveals that GAG represent potent inhibitors of TG2 crosslinking activity and offers atom-detailed mechanistic insights.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>35922533</pmid><doi>10.1038/s41598-022-17113-2</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2022-08, Vol.12 (1), p.13326-13326, Article 13326
issn 2045-2322
2045-2322
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ec1ce90abb794cc0b3ccdc64ff3a478e
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central(OpenAccess); Full-Text Journals in Chemistry (Open access); Springer Nature - nature.com Journals - Fully Open Access
subjects 631/114
631/45
631/535
631/92
Binding sites
Cancer
Celiac disease
Cell adhesion & migration
Chemical bonds
Chondroitin sulfate
Conformation
Enzymes
Extracellular matrix
Glycosaminoglycans
Heparan sulfate
Heparin
Humanities and Social Sciences
Hyaluronic acid
Molecular modelling
multidisciplinary
Peptides
Physiology
Proteins
Science
Science (multidisciplinary)
Sulfates
Transglutaminase 2
Wound healing
title Sulfated glycosaminoglycans inhibit transglutaminase 2 by stabilizing its closed conformation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T16%3A09%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sulfated%20glycosaminoglycans%20inhibit%20transglutaminase%202%20by%20stabilizing%20its%20closed%20conformation&rft.jtitle=Scientific%20reports&rft.au=M%C3%BCller,%20Claudia%20Damaris&rft.date=2022-08-03&rft.volume=12&rft.issue=1&rft.spage=13326&rft.epage=13326&rft.pages=13326-13326&rft.artnum=13326&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-022-17113-2&rft_dat=%3Cproquest_doaj_%3E2698631931%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c447t-57c9e2fb39c1b41c6057209c4cedf9bcd6bef04f52c6b2f6262dd940d51af3d13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2697537137&rft_id=info:pmid/35922533&rfr_iscdi=true